Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 948 publications
Targeting the CXCR4/CXCL12 Axis to Overcome Drug Resistance in Triple-Negative Breast Cancer.
Journal: Cells
Published: August 08, 2025
The role of heparin in autologous stem cell mobilization in patients with multiple myeloma.
Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
Published: June 26, 2025
Analysis of remobilization efficiency of etoposide combined with cytarabine and pegfilgrastim, with or without plerixafor, for multiple myeloma recurrence following autologous hematopoietic stem cell transplantation.
Journal: Clinical and experimental medicine
Published: June 19, 2025
NQO1/p65/CXCL12 Axis-Recruited Tregs Mediate Resistance to Anti-PD-1 Plus Lenvatinib Therapy in PIVKA-II-Positive Hepatocellular Carcinoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 18, 2025
Bifunctional chelator-plerixafor complex for targeting CXCR4 receptors: radiolabeling, in-vitro, and preclinical study.
Journal: Nuclear medicine communications
Published: June 17, 2025
The Impact of Anti-CD38 Monoclonal Antibody Therapy on Stem-Cell Mobilization Yields in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Referred from Community and Academic Oncology Practices: Single Center, Real World Data 2021-2024.
Journal: Transplantation and cellular therapy
Published: June 16, 2025
Efficacy of chemotherapy with G-CSF versus plerixafor with G-CSF in autologous stem cell mobilization for lymphoma patients.
Journal: American journal of cancer research
Published: June 13, 2025
Inhibition of Cxcr4 chemokine receptor signaling improves habituation learning and increases cAMP-PKA signaling in a zebrafish model of Neurofibromatosis type 1.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2025
PAMD-Ch17, a Polymeric Analog of Plerixafor, Induces Mitochondrial Dysfunction in T-ALL Cells Independent of CXCR4.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2025
Treatment Accessibility, Availability, and Healthcare Costs for Multiple Myeloma in South Asian Countries.
Journal: Clinical lymphoma, myeloma & leukemia
Published: May 13, 2025
Selective TCRαβ+ and CD45RA+ T-cell depletion of hematopoietic stem cell graft: An analysis on factors that affect depletion performance.
Journal: Cell transplantation
Published: May 09, 2025
Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM Syndrome.
Journal: medRxiv : the preprint server for health sciences
Published: May 07, 2025
Last Updated: 10/31/2025